GOLDENWELL BIOTECH, INC.
GWLL · OTCMCIK 1800373fmd_1C15M9FFCSKJ8S1NNJ0VNQZ149Manufacturing · Food and Kindred ProductsTemplate: Standard
Coverage: Jan 01, 2019 to Jun 30, 2026, 28 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 0 | 0 | 0 | – | – | – | – |
| Total operating expenses | 0 | 0 | (0) | 1 | 0 | 0 | 0 |
| Operating income | (0) | (0) | (0) | (1) | (0) | (0) | (0) |
| Non-interest expense | – | – | – | – | 0 | 0 | – |
| Interest expense | 0 | 0 | 0 | – | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | 0 | 0 | 0 | – | – | – |
| Income before taxes | (0) | (0) | (0) | – | (0) | (0) | – |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (0) | (0) | (0) | – | (0) | (0) | – |
| Net income | (0) | (0) | (0) | (1) | (0) | (0) | (0) |